Five different methods for the estimation of the binding potential, a measure of Bma)Kd' of p1C]ra_
clopride in human striatum were compared using data from a dose ranging study of the neuroleptic CP-88,059-01. Binding potential was estimated indirectly, from dis tribution volumes in striatum and cerebellum, using both single-and two-tissue compartment models with a metab olite-corrected plasma curve as input function. The two tissue compartment model was also used for a direct estimate of the binding potential. In addition, a direct estimate was obtained from the reference tissue compart ment model using the cerebellum as indirect input func tion. Finally, an estimate of binding potential was calcu lated from the ratio of striatum over cerebellum counts at late times after injection. The estimates of striatum bind ing potential from all methods, except the direct determi-
The highly selective antagonist [llC]raclopride (Farde et aI., 1985; Kohler et aI., 1985) is widely used with positron emission tomography (PET) for the assessment of dopamine D2 receptors in patients with movement disorders (Brooks et aI., 1991 (Brooks et aI., , 1992 Rinne et aI., 1993b; Sawle et aI., 1993) and schizo phrenia (Farde et aI., 1987 (Farde et aI., , 1992 Nordstrom et aI., 1992) . In addition, its successful use in measuring the occupancy of D2 receptors by neuroleptics has been described (Farde et aI., 1988b (Farde et aI., , 1992 Bench et aI., 1993; Leenders et aI., 1993) .
A variety of methods for data collection and anal-nation using a two-tissue compartment model with me tabolite-corrected plasma input function, correlated with each other. Use of an average metabolite correction re sulted in only a small reduction in accuracy in this series of normal subjects. The reference tissue model provided estimates of the binding potential with the same sensitiv ity for detecting changes as those methods that required a metabolite-corrected plasma input function. This indi cates that for routine analysis of clinical [ ll C]raclopride studies, no arterial cannulation is required. The range of normal values was significantly less variable with the ref erence tissue method than when simple striatum-to cerebellum ratios were used. Key Words: Positron emis sion tomography-[IIC]raclopride-Dopamine Dz recep tors-Tracer kinetic modelling.
ysis of e IC]raclopride studies have been described. These include simple striatum-to-cerebellum ratios at a certain time after tracer injection (Brooks et aI., 1991 (Brooks et aI., , 1992 Nordstrom et aI., 1992; Antonini et aI., 1993; Leenders et aI., 1993; Rinne et aI., 1993b; Volkow et aI., 1993) , compartmental analysis of tis sue time-radioactivity curves using either a metab olite-corrected plasma (Farde et aI., 1989; Sawle et aI., 1993; Volkow et aI., 1993) or reference tissue (Hume et aI., 1992b; Bench et aI., 1993) input func tion, and equilibrium studies in the same individual (Farde et aI., 1986; Rinne et aI., 1993a) . It is clear that the reported methods for perform ing [llC] raclopride studies differ greatly both in terms of accuracy as well as in complexity. The purpose of the present study was to identify the method that is best suited for routine analysis of clinical studies. Consequently, only those methods involving a single bolus administration of the tracer were considered. To test the various methods over a range of receptor occupancies, each was applied to the data obtained in a D2 receptor occupancy study of the neuroleptic CP-88,059-01 .
METHODS

Subjects
Eight normal male subjects with age ranges 20--34 years were studied. One subject received placebo and the other subjects one of seven different doses of CP-88,059-1, 6 h before scanning. Age, weight, and dose of CP-88,059-1 for the eight subjects are given in Table 1 . Further study details of the subjects have been described previously (Bench et aI. , 1993) .
All subjects gave their informed consent before scan ning. The studies were approved by the Research Ethics Committee of Hammersmith Hospital. Permission to ad minister the radioactive tracers was obtained from the United Kingdom Administration of Radioactive Sub stances Advisory Committee.
Scanning protocol
After establishing the presence of satisfactory collat eral circulation and subcutaneous infiltration with 0. 5% bupivacaine (Marcain), a 22-g Teflon cannula was in serted into the left radial artery. Subjects were positioned in an ECAT 931-08/12 (Cn Inc., Knoxville, TN, U. S.A. ) positron emission tomograph (Spinks et aI. , 1988) so that transaxial slices were parallel to the orbitomeatal line. Head movement was restricted by individual moulded polystyrene head supports and a transmission scan was acquired for the purpose of attenuation correction.
Each subject received a bolus intravenous injection of a saline solution of [llC1raciopride, which was prepared as described previously (Farde et aI. , 1988a) . Details of injected doses (radioactivity and amount of raclopride) are listed in Table 1 . Starting 30 s before time of injection, 22 sequential frames were collected during 60. 5 min ac cording to the following protocol: 1 x 30 s (background frame), 6 x 5 s, 3 x 10 s, 4 x 60 s, 2 x 150 s, 2 x 300 s, and 4 x 600 s.
Arterial whole blood was withdrawn continuously from the radial artery cannula at a rate of 5 mllmin for the first 10 min and 2.5 mllmin thereafter. The on-line detection system, cross-calibrated against the PET scanner, has been described previously (Lammert sma et aI. , 1991) , ex cept that now nonsticking polytetrafluoroethylene tubing was used. At set times (5, 10, 20, 30, 40 , and 60 min after injection) continuous blood withdrawal was interrupted briefly for the collection of blood samples that were used to estimate plasma-to-whole-blood ratios and were ana-lyzed for e lC1raciopride metabolites as described else where (Luthra et aI., 1993) . After each sample, the arte rial line was flushed with heparinised saline.
Using the continuously monitored arterial whole blood curve and the discrete arterial samples, a plasma curve (corrected for circulating metabolites) was generated as described previously (Lammertsma et aI. , 1991) , except that a compartment model with total plasma as the input function was used to fit the buildup of metabolites in plasma (Lammert sma et aI. , 1993) .
Image analysis
All emission scans were reconstructed using a Hanning filter with a cutoff frequency 0.5 of maximum. This re sulted in a spatial resolution of 8. 4 x 8.3 x 6.6 mm full width at half maximum at the centre of the field of view (Spinks et aI. , 1988) .
After reconstruction, the dynamic images were trans ferred to a workstation (model 3/60, Sun Microsystems, Mountain View, CA, U. S.A.) and analyzed using image analysis software [Analyze version 3.0, Biodynamics Re search Unit, Mayo Foundation, U. S.A. (Robb and Han son, 1991) 1. Average whole brain, striatum, and cerebel lum time-radioactivity curves were generated using re gions of interest (ROI), which were defined in a standardized manner as described elsewhere (Sawle et aI. , 1990; Bench et aI. , 1993) . The average striatum ROI comprised a volume of 6.8 ml; the average cerebellum ROI was 22.9 ml.
Kinetic analyses
To obtain the delay parameter that was required to ac count for the difference in arrival between activity in the external blood detection system compared with that in the brain, the whole brain time-radioactivity curves were fitted for K1, k2, k3' k4, Vb' and delay of the blood curves, using a standard two-tissue compartment model and non linear regression techniques with the arterial whole blood and metabolite-corrected arterial plasma curves as input functions (Appendix A: Eq. A. 5 with A. 4, with appropri ate delay terms included). Here K l and k2 are the rate constants for transfer of [IIC1raciopride from plasma to brain and vice versa, k3 and k4 are the rate constants for transfer between free and bound e lC1raciopride in tissue, and Vb is the fractional blood volume within the brain. Use of the metabolite-corrected plasma curve was based on reports that the labelled metabolites do not cross the blood-brain barrier (Kohler et aI. , 1985; Ross and Jack son, 1989 ). In the further analysis, where regional time radioactivity curves were fitted, the blood delay was fixed to the value obtained from the whole brain.
Striatum and, where appropriate, cerebellum time- A description of the compartment models used in meth ods A, B, and C is given in appendices A, B, and C, respectively.
In method A, the metabolite-corrected arterial plasma curve and the uncorrected arterial whole blood curve (to estimate blood volume) were used to fit the striatum curves for K I , k2, k3, binding potential (BP) ( = k3/k4), and Vb (Eq. A.5 with AA and A.6). The ratio of k3 over k4' the binding potential BP, is a measure of Bmax over Kd and tends to be more stable than the individual rate con stants (Rume et aI., 1992b).
Apart from the aforementioned direct estimation of BP, method A was also used in an indirect manner. In this approach, a similar two-tissue compartment fit was also applied to the cerebellum curves. Then the volumes of distribution of [IIC]raciopride (V d) in both striatum (V dJ and cerebellum (V dc) were calculated using V d = (K I I k2Hl + k3/k4) with K I to k4 from the striatum and cer ebellum fits, respectively. Striatal binding potential was finally calculated from BP = (V ds -V dc)1V dc'
In method B, the metabolite-corrected arterial plasma curve and the uncorrected arterial whole blood curve were used to fit both the striatum and cerebellum curves for K I , Vd (=K l /k2), and Vb (Eq. B.2 with B.l and B.3). Fitted values of V d in striatum (V ds) and cerebellum (V dc) were then used indirectly to estimate striatal binding po tential from BP = (V ds -V dc)1V dc'
In method C, the cerebellum time-radioactivity curve was used as an (indirect) input function to the striatum curve. This method has previously been described for the analysis of [IIC]raciopride PET data in small laboratory animals (Rume et aI. , 1992b), in which the collection of individual metabolite-corrected plasma curves is difficult to perform, and provides best estimates for BP, k2, k3' and the ratio of the K I values for striatum and cerebellum (Eq. C.7).
Blood sampling was also not required for method D. This approach assumes that when a constant ratio has been achieved (i.e., when clearance rates from plasma and tissue are similar), the ratio R reflects V dslV dc' In the present study, R was calculated from the counts in stria tum and cerebellum over the period from 30 to 60 min after [IIC]raciopride injection. Striatal binding potential was then calculated from BP = R -1.
The fits obtained with methods A, B, and C were com pared using the Akaike (Akaike, 1974) and Schwarz (Schwarz, 1978) criteria and the F statistic (Cunningham, 1985) .
Supplementary analyses
To assess the effect of variations in plasma metabolite fractions, the analyses using methods A and B were re peated, using individual plasma input functions, gener ated in a manner identical to that described previously herein, except that the individual metabolite sample data were replaced by the average of the eight subjects.
In order to compare the variability within methods C and D, both analyses were also applied to data from a J Cereb Blood Flow Metab. Vol. 16, No. I, 1996 different group of seven healthy normal male subjects (Bench et aI., 1993) , who did not receive any medication and in whose studies no blood data were collected.
RESULTS
The metabolite-corrected plasma time-radio activity curve, together with striatum and cerebel lum time-radioactivity curves for subject 4 (pla cebo) are shown in Fig. 1 . Curves were similar for the other studies except that, as expected, the stri atum curve became progressively reduced with in creasing dose of CP-88 ,059-1. The plasma-to-whole blood ratios were constant, both over time and over subjects (mean ± SD = 1.62 ± 0.03), and no cor relation between formation of plasma metabolites ( Fig. 2) and dose of CP-88,059-1 was found.
In Fig. 3 , fits of the striatum time-radioactivity curve for subject 4 (placebo) are shown for methods A (two-tissue compartments with plasma input), B (one-tissue compartment with plasma input), and C (reference tissue with cerebellum input). In this subject, method A provided the best fit according to Akaike and Schwarz criteria, although the differ ence with method C was small (p < 0.01; F statis tic). Both methods A and C were significantly better than method B (p < 0.001; F statistic). Similar re sults were found for the striatum curves of the other subjects. According to Akaike and Schwarz crite ria, the two-tissue compartment model (method A) performed best in five subjects, whereas the refer ence tissue model (method C) was best in the other three studies. The F statistic showed a similar pat tern.
Analysis of the cerebellum curves revealed that, with the metabolite-corrected plasma curve (solid line), for subject number 4 (predosed with placebo). The metabolite corrected plasma curve was generated according to Lam mertsma et al. (1993) . in all cases and with all three criteria, significantly better fits were obtained with method A (two-tissue compartments) as compared with those obtained with method B (one-tissue compartment).
The values of the volume of distribution of raclo pride in both cerebellum and striatum are given in Table 2 . Although the differences were relatively small, it is clear from this table that the two-tissue compartment model gave systematically higher val ues than the single-tissue compartment model.
In Table 3 values for the calculated and fitted binding potentials are given for the four methods. Note that for method A two values are given, one obtained directly from the fit, the other indirectly from the volumes of distribution. As illustrated in Fig. 4 , a good correlation between BP values ob tained with the various methods was found, with the exception of the direct estimation of BP using method A, which did not correlate with any of the other methods. This lack of correlation was due to the fact that, although good fits were obtained with method A, the fitted BP parameters had high stan dard errors, ranging from 19 to 77%. Dose-response curves for the other four BP esti mates are given in Fig. 5 . As expected from the correlation between these parameters, all dose response curves showed a similar and consistent pattern.
Use of an average rather than individual metab olite correction had little effect on the indirect (through V d) estimation of BP using method A (two tissue compartments). The range of BP values ra . nged from 3% lower to 4% higher when compared With the corresponding values from the analyses us ing individual metabolite corrections, despite the fact that individual V d values for striatum and cer ebellum were up to 15% different. For method B (single-tissue compartment) the difference in BP values using average compared with individual me tabolite corrections ranged from -5 to -13%.
Application of the reference tissue model 
FIG. 4. Correlation between estimates of binding potential (BP) obtained with the various methods and those obtained with the indirect application of method A, where BP was cal culated from cerebellum and striatum V d values. Method A-direct refers to the directly fitted BP parameter with method A. The straight lines were obtained with linear re gression analysis.
(method C) to a different group of seven normal controls resulted in a BP value of 2.20 ± 0.31 (mean ± SD), which was similar to the value obtained for the placebo study (subject 4). BP calculated from the ratio (method D) for the same group of subjects was 2.38 ± 0.72.
DISCUSSION
The ideal method for the analysis of clinical PET data is often a tradeoff between accuracy and sim plicity. Given the widespread use of e IC]raclopride and the variety of reported tracer procedures (see beginning of this article), a comparison between various methods seemed appropriate.
The methods were applied to data obtained from a dose-ranging study of the neuroleptic CP-88,059-01. The pharmacokinetic aspects and results of this dose-ranging study have previously been published (Bench et aI., 1993) . Although the number of sub jects (n = 8) was relatively small for a comparative study, this disadvantage was outweighed by the possibility to test the various methods over a wide range of receptor occupancies. Because neither CBF (Bench et aI., 1993) , nor the formation of la belled metabolites (Fig. 2) were correlated with the administered dose of CP-88,059-1, extrapolation of the results to clinical situations of reduced receptor densities seems reasonable. The level of labelled metabolites as a function of time ( Fig. 2 : range 25-46% at 40 and 25-50% at 60 min after injection) was similar to that previously reported by Swahn et ai. (1992) (24% at 42 min after injection) and Volkow et ai. (1993) (32% at 60 min after injection).
J Cereb Blood Flow Metab, Vol. 16, No. 1, 1 996 U sing metabolite-corrected input functions (methods A and B) for cerebellum and striatum, K I values ranging from 0.10 to 0.15 were found, corre sponding with a first-pass extraction fraction of -20%, similar to that of a previous report (Farde et aI., 1989) . Also confirming Farde's earlier work was the finding that two-tissue compartments were pre ferred for the cerebellum fits. The absence of D2 receptors in the human cerebellum (Fields et aI., 1977; Camps et aI., 1989) , the fact that the labelled metabolites of e IC]raclopride do not cross the blood-brain barrier (Kohler et aI., 1985; Ross and Jackson, 1989) , and the fact that k3 values are not reduced by a decrease in specific activity of e IC] raclopride (Farde et aI., 1989 ) would indicate that this second tissue compartment represents nonspe cific binding that is not infinitely fast. This was con firmed by the lack of correlation between cerebel lum V d and dose of CP-88,059-1. Based on K/k2 ratios and total V d values (both from method A), a contribution of -25% of the total cerebellum V d could be attributed to the second tissue compart ment, which is higher than the 5-10% nonspecific binding found in rat brain (Kohler et aI., 1985) . It should be noted, however, that the second compart ment is not required for rat cerebellum (Hume et aI., 1992b) and that for other ligands nonspecific binding has been shown to be higher in human brain than in rat brain (e.g., Hume et aI., 1992a ). An al ternative explanation for the presence of two-tissue compartments would be the existence of parallel, rather than sequential, compartments as a result of heterogeneity within the sampled cerebellum (i. e., grey and white matter). On statistical grounds, both methods A and C provided significantly better fits to the striatum data than method B, although in practice the differences were relatively small (Fig. 3) . For example, calcu lated V d was on average only 5% higher with method A than with method B (8% for cerebellum, Table 2 ). In this small series of subjects, no consis tent difference between methods A and C was seen, with method A providing the best fits in five and method C in three SUbjects, respectively.
It is well established that a single tracer adminis tration study does not permit the measurement of Bmax and Kd separately (Mintun et aI., 1984) . How ever, the binding potential BP ( = k3/k4), a measure of Bma)Kd' is a useful parameter for the quantifi cation of receptor binding characteristics (Hume et aI., 1992b) . This parameter, which is also more sta ble than individual k3 and k4 values was, therefore, selected for the comparison of the various methods. BPs were obtained directly from the fits (fitting for k3/k4' methods A and C) or indirectly calculated from striatum and cerebellum V d (methods A and B) or from the ratio of striatum over cerebellum counts at late times (30--60 min, method D).
With the exception of the directly fitted BP using method A, all estimates of BP (Table 3) correlated with each other (Fig. 4) and resulted in similar dose-response curves for CP-88,059-1 (Fig. 5) . The failure of the direct application of method A was due to the instability of the parameter BP (high stan dard errors), probably related to the relatively poor separation of the two compartments, as indicated by the small difference between two-and single tissue compartment fits in Fig. 3 . On the other hand, the total volume of distribution for striatum and cerebellum should be determined more accu rately with the inclusion of a second tissue compart ment (better fits) and, therefore, the indirect mea surement of BP using method A should be a better estimate of BP than that obtained with method B. However, differences were small (Fig. 4, Table 3 ).
It should be noted that, although a good correla tion between methods existed, quantitative differ ences were observed, with the highest BP estimates from the ratio and the lowest from the reference tissue method. One possible explanation for these quantitative differences is a potential difference in the effect of nonspecific binding on the estimation of BP. For example, if the kinetics of the nonspe cific binding were described by ks and k6 [i.e., Vd s = (K1/k2)'(1 + k3/k4 + ks/k6) and V de = (K/k2) · (1 + ks/k6)], it can be seen that the indirect methods [i.e., using BP = (V d s -V de)IV de] would underes timate true BP by a factor 1 + ks/k6' provided non specific binding was the same in striatum and cer-ebellum. If the second tissue compartment in the cerebellum were representative of nonspecific bind ing, this underestimation would be on average -20%. Possible higher levels of nonspecific binding in the striatum than in the cerebellum, as suggested by Seeman et al. (1990) , would tend to reduce this underestimation. For example, for normal BP, a 35% higher level of nonspecific binding in the stri atum would lead to an overestimation of <5%. However, this effect would be dependent on the BP itself and could rise to -15% for the studies with the highest doses of CP-88,059-1.
The two different effects of nonspecific binding would also apply to the estimation of BP from the ratio (method D). However, even in the absence of nonspecific binding, the ratio from a secular equi librium study tends to overestimate BP to a degree that is dependent on tissue kinetics and the rate of plasma clearance (Carson et aI., 1993) . Thus, the tissue concentration at any given time is related to the history of the plasma curve, not the instanta neous (decreasing) plasma concentration.
The effects of nonspecific binding on the estima tion of BP using the reference tissue model (method C) is more complicated. Theoretically, the model is only correct if the cerebellum can be described by a single-tissue compartment (Hume et aI., 1992b) . It has been reported that a small amount of specific binding in the reference tissue can underestimate Bmax for the target tissue with a much smaller effect on Kd (Cunningham et aI., 1991) . Similarly, an un derestimation of BP would be expected if nonspe cific binding in the reference tissue had to be de scribed by a second tissue compartment. However, this effect would be somewhat counteracted by the presence of possibly a higher degree of nonspecific binding in the striatum.
It should be noted that the tracer kinetic descrip tion provided in Appendices A, B, and C is related to the the total concentration of unmetabolised [llC]raclopride. If significant protein or lipid bind ing in plasma exists, only part of the e lC]raclopride (free fraction) will be available for transfer from plasma to tissue (Mintun et aI., 1984) . However, this will only affect K l and the apparent volume of distribution of free [llC]raclopride (K1/k2). BP ( = k3/k4), as obtained by any of the models de scribed here, will not be affected. Nonspecific bind ing in tissue has been discussed previously herein for the case in which its kinetics is such that it needs to be described by additional rate constants ks and k6. If, on the other hand, the kinetics of nonspecific binding in tissue is very fast, the equations in Ap pendices A, B, and C are still valid. In particular, there is no affect on the k3/k4 ratio. The free fraction in tissue, providing the truly free e lC]raclopride in tissue (Mintun et at., 1984) , becomes important when this k3/k4 ratio is compared with the in vitro B m axlKd ratio.
The close correlation between most of the BP estimates (Fig. 4) indicates that all these methods, except the direct estimation of BP using method A, showed a similar sensitivity toward changes in BP. For methods A (indirect) and B, use of an average metabolite correction resulted in only a small loss of accuracy with respect to the estimation of BP, in particular for the indirect application of method A «5%). This is due to the fact that the basic step in the calculation of BP is a division of two V d values (striatum and cerebellum). Both will be affected in a similar manner by a slight change in the tail of the plasma curve, which can result from a change in metabolite correction. It should be emphasised that the aforementioned finding has been obtained in a group of normal subjects. It is possible that certain disease states or coadministered therapeutic agents might alter hepatic metabolism, resulting in system atic changes in tracer metabolic profiles. Because this may lead to artificial between-group differ ences, use of an average metabolite correction needs to be validated in each patient population separately.
Although in the present study the labour intensive measurements of plasma metabolites could be omitted from methods A and B, by using an average metabolite correction, methods C (ref erence tissue) and D (ratio) have the additional ad vantage that no metabolite-corrected plasma input function at all is required. Consequently, no arterial cannulation is required for these methods. In addi tion, because methods C and D are independent of the plasma curve, they are also independent of the tracer metabolic profile and, thereby, of possible errors in the measurement of metabolites.
Both linearised (Blomqvist, 1984) and graphic (Logan et at., 1990) variations of methods A and B have been described. However, these methods still require a measured (metabolite-corrected) arterial plasma input function. The main finding of the present study is that alternative methods exist that do not require arterial sampling and measurement of plasma metabolites. Therefore, only a compari son with the standard single (B) and two (A)-tissue compartment models seems sufficient.
Method D has the advantage that, in principle, only a single scan is required that can be initiated 30 min after injection. However, in practice, the gain in time is less. A transmission scan is still required for attenuation correction purposes. In addition, the overestimation of BP from the ratio is dependent on J Cereb Blood Flow Metab, Vol. 16, No. 1, 1996 BP itself and could be different in situations of low flow. The reference tissue method, on the other hand, takes flow changes into account and provides a measure of striatum flow relative to cerebellum flow (Hume et at., 1992b) . Finally, the ratio method only uses 30 min of data collection, starting 1.5 half lives after injection. In contrast, the reference tis sue method uses all data. Results of a further study on seven normal subjects were in agreement with the latter argument. The coefficients of variation of BP were 14% for method C and 30% for method D, respectively.
As already mentioned, the only method that did not require the use of cerebellum data (direct esti mation of BP using method A) provided unsatisfac tory results. All other methods made use of cere bellum data and should, therefore, be used with caution in the presence of cerebellar disease. In par ticular, cerebellar atrophy (e.g., mUltiple systems degenerations, anticonvulsant/seizure-associated cerebellar atrophy, alcohol exposure, or toxic/ metabolic conditions) may affect the estimation of cerebellum tracer levels due to partial volume ef fects, thereby invalidating method D. Because the volume of distribution will be affected to the same extent, methods A and B also will be compromised. It is of interest to note that partial volume effects will primarily result in an underestimation of K 1, but not of k2 (fractional clearance rate). Although the reference tissue model allows for differences in Kl between striatum and cerebellum, method C will also be affected by cerebellar atrophy, because the assumption of equal volumes of distribution of not specifically bound tracer in striatum and cerebellum (Eq. C.6) is no longer valid.
CONCLUSIONS
A number of methods for the analysis of single injection e lC]raclopride PET studies provided esti mates of striatum BP that correlated well with each other, despite some quantitative differences. Of the methods tested, only the direct fitting of BP using a metabolite-corrected plasma curve as input func tion did not provide reliable estimates.
The reference tissue compartment model and count ratio methods, in avoiding arterial cannula tion, greatly simplify both data collection and anal ysis procedures. Both methods can be used for the analysis of routine clinical studies, without sacrific ing the sensitivity for detecting changes in specific binding. Based on the safeguard against possible breakdown of underlying assumptions and possibly also on statistical grounds, the reference tissue method is to be preferred.
APPENDIX A
In Fig. Al a schematic diagram of a two-tissue compartment model as applied to PET studies is given. It shows the calculation of the plasma input function from the continuously measured arterial whole blood time-activity curve, indicating the cor rections for labelled blood cells and metabolites. The differential equations relating to this compart ment model follow from Fig. Al and are well known:
where Cp = Metabolite-corrected plasma con centration (kBq ml-I) Cf = Concentration of free (i.e. not spe cifically bound) ligand (kBq ml-') C b
Concentration of specifically bound ligand (kBq ml-') K, Rate constant for transfer from plasma to free compartment (ml ml-I min-I) k2
Rate constant for transfer from free to plasma compartment (min -I) k3
Rate constant for transfer from free to bound compartment (min -I) k4 = Rate consant for transfer from bound to free compartment (min -I)
In practice, only the total concentration Ct within a region is measured. This is related to the free and bound concentrations by:
A.3
From Eqs. A.I to A.3 the usual relationship be tween the tissue concentration Ct and the metabo- lite-corrected plasma concentration Cp for a two tissue compartment model, as function of time, can be derived:
However, with PET a macroscopic ROI will be sampled that will contain a significant contribution from intravascular activity in the early phase after a bolus injection. This "background" signal will not depend on the plasma concentration, but on all ac tivity within the intravascular space, i.e., the whole blood concentration Ca. directly, which was the approach adopted for the direct estimation of BP. It should be noted that previous equations have been derived for negligible nonspecific binding of the tracer. However, if the kinetics of nonspecific binding are fast, the previous equations are still valid, because the rapid exchange between free and nonspecific pools effectively increases the free compartment. On the other hand, for slower non specific kinetics, the kik4 ratio will contain a non specific component. For the cerebellum this ratio will be dominated by nonspecific binding. where C = Metabolite-corrected plasma conp centration (kBq ml-I) C = r Concentration in reference tissue (kBq ml-I) Cf = Concentration of free (i.e. not specifically bound) ligand (kBq ml-I) Cb
Concentration of specifically bound ligand (kBq ml-I) K I Rate constant for transfer from plasma to free compartment (ml ml-I min-I) k2
Rate constant for transfer from free to bound compartment (min -I) k4
Rate constant for transfer from bound to free compartment (min -I) K;
Rate constant for transfer from plasma to reference compartment (ml ml-I min -I) k' 2 Rate constant for transfer from reference to plasma compartment (min -I)
As mentioned in Appendix A, in practice only the total concentration Ct within a "specific" region is measured. This is related to the free and bound con centrations by:
C.4
From Eqs. C.l to C.4 it is possible to derive a re lationship between Ct and C r that contains K I to k4' K I ' and k2" but not Cf, C b , and C p o However, this equation still contains six parameters with the rate constants K I and K I ' only entering as a ratio. This ratio accounts for differences in delivery between specific and reference tissue. Substituting C.5 and assuming that the volume of distribution of the Using standard nonlinear regression analysis, Eq. C.7 can now be used to obtain best estimates for R" k2' k3' and BP (after substitution of BP = k3/k4) from the measured tissue concentrations CtCt) and C/t), without the need for measuring Cp(t). The op erational equation takes into account differences in delivery between specific and reference tissue (R,). In addition, it does not assume that Cr(t) equals CrCt) ·
